Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)*-Reference-Cited by-同舟云学术

Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)*

Published:2021-05-04 Issue:2 Volume:185 Page:323-334
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Thaci D.¹,Piaserico S.²^ORCID,Warren R.B.³,Gupta A.K.⁴⁵^ORCID,Cantrell W.⁶,Draelos Z.⁷,Foley P.⁸,Igarashi A.⁹,Langley R.G.¹⁰,Asahina A.¹¹,Young M.¹²,Falqués M.¹³,Pau‐Charles I.¹³,Mendelsohn A.M.¹⁴,Rozzo S.J.¹⁴,Reich K.¹⁵^ORCID

Affiliation:

1. Institute and Comprehensive Centre for Inflammation Medicine University of Lübeck Ratzeburger Allee 160 Lübeck 23538Germany

2. Dermatology Unit Department of Medicine University of Padua Via Vincenzo Gallucci 4 Padua 35128Italy

3. The Dermatology Centre Salford Royal NHS Foundation Trust Manchester NIHR Biomedical Research Centre The University of Manchester Manchester M6 8HDUK

4. Division of Dermatology Department of Medicine University of Toronto School of Medicine 190 Elizabeth Street, R. Fraser Elliott Building, 3‐805 Toronto ON M5G 2C4Canada

5. Mediprobe Research Inc 645 Windermere Road London ON N5X 2P1Canada

6. Village Dermatology 2900 Cahaba Road Birmingham AL 35223USA

7. Dermatology Consulting Services 2444 North Main Street, High Point NC 27262USA

8. Skin Health Institute Inc. Level 1, 80 Drummond Street Carlton Victoria 3053Australia

9. NTT Medical Center Tokyo 5‐9‐22 Higashi‐Gotanda, Shinagawa‐ku Tokyo 141‐8625Japan

10. Division of Dermatology Department of Medicine Dalhousie University 6054 Coburg Road Halifax NS B3H 1Z2Canada

11. Department of Dermatology The Jikei University School of Medicine 3‐25‐8, Nishi‐Shimbashi, Minato‐ku Tokyo 105‐8461Japan

12. Mindful Dermatology Modern Research Associates 9101 N Central Expy Ste 160 Dallas TX 75231USA

13. Almirall R&D Carrer de Laureà Miró, 408, 410 Sant Feliu de Llobregat, Barcelona 08980Spain

14. Sun Pharmaceutical Industries, Inc. 2 Independence Way Princeton NJ 08540USA

15. Translational Research in Inflammatory Skin Diseases Institute for Health Services Research in Dermatology and Nursing University Medical Center Hamburg‐Eppendorf M Hamburg 20246Germany

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19866

Reference28 articles.

1. French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults

2. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017

3. Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders